Close

More on AB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-12.9% Growth)
- Ratings (5.4 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/14/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AllianceBernstein (NY:AB)
Delayed: 28.42 -0.01 (0.04%)
Prev. Close $28.43  
Open$28.43 
52 Wk High$26.24 
52 Wk Low$16.11 
Day High$29.02 
Day Low$28.34 
P/E 16.72  
EPS$1.70 
Volume511,188 

Friends, Peers and Foes (?): EQH, HYFI, LULU, ZG, FWD (more...)

Dec 5, 2023 07:30 AM AllianceBernstein Announces Launch of NAV Lending Strategy
Dec 4, 2023 06:19 PM Form 4 ALLIANCEBERNSTEIN HOLDIN For: Dec 01 Filed by: Erzan Onur
Dec 4, 2023 06:16 PM Form 4 ALLIANCEBERNSTEIN HOLDIN For: Dec 01 Filed by: Siemers William R
Dec 4, 2023 06:15 PM Form 4 ALLIANCEBERNSTEIN HOLDIN For: Dec 01 Filed by: Simeone Thomas
Dec 4, 2023 06:14 PM Form 4 ALLIANCEBERNSTEIN HOLDIN For: Dec 01 Filed by: Sprules Karl
Dec 4, 2023 06:14 PM Form 4 ALLIANCEBERNSTEIN HOLDIN For: Dec 01 Filed by: BERNSTEIN SETH P
Dec 4, 2023 06:13 PM Form 4 ALLIANCEBERNSTEIN HOLDIN For: Dec 01 Filed by: MANLEY MARK R
Nov 28, 2023 01:22 PM AB Science will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present the masitinib development program in sickle cell disease
Nov 27, 2023 02:04 AM AB Science: The clinical development of masitinib in sickle cell disease is among the 19 winning projects under the sixth call for “Hospital-Inuversity Research in health (RHU)”
Nov 21, 2023 12:44 PM Seth Bernstein, President and CEO, to Participate in the Goldman Sachs 2023 US Financial Services Conference on December 5th, 2023
View All Articles

Entities mentioned with AB

View All Entities